Company news

Share this article:
Roche was ordered to pay $12,895,500 to three plaintiffs claiming the drugmaker's acne medication, Accutane, caused inflammatory bowel disease that resulted in permanent injuries. The case was heard in a New Jersey Superior Court, and then transferred to an Accutane mass tort case in New Jersey's Atlantic County.
 
WellDoc Communications (a technology solutions company focused on chronic disease management) and dLife (a diabetes multimedia network) have announced a partnership. The partnership combines WellDoc's web- and moble-based diabetes management tools with dLife's online patient support tools.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.